Washington-based Seagen bought by Pfizer for $43B, boosts access to cancer drugs

South Africa News News

Washington-based Seagen bought by Pfizer for $43B, boosts access to cancer drugs
South Africa Latest News,South Africa Headlines
  • 📰 komonews
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 63%

Bothell, Washington-based Seagen Inc. specializes in working with antibody-drug conjugate, or ADC, technology.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

komonews /  🏆 272. in US

South Africa Latest News, South Africa Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Pfizer buys Seagen for $43B, boosts access to cancer drugsPfizer buys Seagen for $43B, boosts access to cancer drugsPfizer will spend $43 billion to buy Seagen and deepen its reach into treating cancer. The pharmaceutical giant said Monday that it will pay $229 per Seagen share.
Read more »

Pfizer to buy Seagen for $43B to enhance reach of cancer drugsPfizer to buy Seagen for $43B to enhance reach of cancer drugsDrugmaker seeks out new revenue sources as expiration of patents protecting drugs like Ibrance from competition nears.
Read more »

Pfizer buys Seagen for $43B, boosts access to cancer drugsPfizer buys Seagen for $43B, boosts access to cancer drugsPfizer is spending about $43 billion to reach deeper into new cancer treatments that target tumor cells while sparing surrounding healthy tissue.
Read more »

Pfizer to pay $43B for Seagen, boosting cancer drug portfolioPfizer to pay $43B for Seagen, boosting cancer drug portfolioThe latest deal comes as Pfizer seeks to mitigate an anticipated $17 billion hit to revenue by 2030 from patent expirations for top drugs and decline in demand for its COVID products.
Read more »

Pfizer buys Seagen for $43B, boosts access to cancer drugsPfizer buys Seagen for $43B, boosts access to cancer drugsPfizer will spend $43 billion to buy Seagen and deepen its reach into treating cancer. The company said it will pay $229 in cash for each Seagen share, combining Seagen’s technology with Pfizer’s scale and strength, Pfizer's CEO said in a statement.
Read more »

Pfizer buys Bothell’s Seagen for $43B, boosts access to cancer drugsPfizer buys Bothell’s Seagen for $43B, boosts access to cancer drugsPfizer is spending about $43 billion to reach deeper into new cancer treatments that target tumor cells while sparing surrounding healthy tissue.
Read more »



Render Time: 2025-03-01 04:20:50